Assessment of Antinuclear Antibodies (ANA): National Recommendations on Behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine

Overview

Journal Biochem Med (Zagreb)

Specialty Biochemistry

Date 2021 Apr 30

PMID 33927550

Citations 10

Authors

Andrea Tesija Kuna

Lovorka derek

Vedrana Drvar

Ana Kozmar

Katarina Gugo

Affiliations

Soon will be listed here.

Abstract

Antinuclear antibodies (ANA) represent a family of autoantibodies targeting ubiquitous cellular constituents and are a hallmark of systemic inflammatory autoimmune rheumatic diseases named connective tissue diseases (CTD). The gold standard method for ANA determination is indirect immunofluorescence (IIF) on the human laryngeal epidermoid carcinoma cell line type 2 substrate (HEp-2), but with increasing demand for ANA testing, novel methods eased for automation emerged, which allows testing by staff less experienced in this specific field of laboratory diagnostic. In 2016 The working group (WG) for laboratory diagnostics of autoimmune diseases as part of the Committee for the Scientific Professional Development of the Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM) published the data of a survey regarding general practice in laboratory diagnostics of autoimmune diseases in Croatia. Results indicated high diversity in the performance of autoantibody testing as well as reporting of the results and indicated the need of creating recommendations for the assessment of ANA that would help harmonize diagnostics of systemic autoimmune rheumatic diseases in Croatia. This document encompasses twenty-seven recommendations for ANA testing created concerning indications for ANA testing, preanalytical, analytical, and postanalytical issues, including rational algorithm and quality control assurance. These recommendations are based on the relevant international recommendations and guidelines for the assessment of ANA testing and relevant literature search and should help to harmonize the approach in ANA testing and clarify differences in interpretation of the results obtained using different methods of determination.

Citing Articles

International Consensus on ANA Patterns (ICAP) Classification Tree Revisited: A Single Centre Report on Four Nuclear Patterns from a Tertiary Care Centre in India.

Ranjan A, Ahmad S, Kumar S, Patra P, Kumar A, Prakash J EJIFCC. 2025; 36(1):37-49.

PMID: 40061060 PMC: 11886623.

Clinical relevance and frequency of cytoplasmic patterns observed in ANA-Hep-2: experience of Cairo University Hospitals.

Abdelraouf F, Soliman O, Khateeb E, Mostafa A Immunol Res. 2024; 72(6):1515-1527.

PMID: 39432152 DOI: 10.1007/s12026-024-09551-z.

Antinuclear antibody (ANA) positivity pattern by line immunoassay in a hospital from eastern India: Update from a laboratory perspective.

Banerjee A, Ranjan A, Kumar M, Kumar S, Bansal A, Mahto M J Family Med Prim Care. 2024; 13(4):1254-1261.

PMID: 38827670 PMC: 11141993. DOI: 10.4103/jfmpc.jfmpc_1170_23.

The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.

Shao H, Wu Y, Tao X, Liu Q, Ran C, Jin L Clin Exp Med. 2024; 24(1):96.

PMID: 38717644 PMC: 11078821. DOI: 10.1007/s10238-024-01357-5.

Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies.

Shurin M, Wheeler S Immunotargets Ther. 2024; 13:215-234.

PMID: 38686351 PMC: 11057673. DOI: 10.2147/ITT.S450184.

References

Man A, Shojania K, Phoon C, Pal J, de Badyn M, Pi D . An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol. 2013; 32(5):601-8. DOI: 10.1007/s10067-012-2141-y. View

Tonutti E, Bizzaro N, Morozzi G, Radice A, Cinquanta L, Villalta D . The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. Auto Immun Highlights. 2016; 7(1):9. PMC: 4947463. DOI: 10.1007/s13317-016-0080-3. View

Infantino M, Meacci F, Bentow C, Martis P, Benucci M, Afeltra A . Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies. J Immunol Res. 2015; 2015:902821. PMC: 4352420. DOI: 10.1155/2015/902821. View

Bossuyt X, Fieuws S . Detection of antinuclear antibodies: added value of solid phase assay?. Ann Rheum Dis. 2013; 73(3):e10. DOI: 10.1136/annrheumdis-2013-204793. View

Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B . Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. Clin Rheumatol. 2013; 32(11):1619-26. DOI: 10.1007/s10067-013-2330-3. View

Agarwal S, Harper J, Kiely P . Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus. Lupus. 2009; 18(5):407-12. DOI: 10.1177/0961203308097784. View

Liberal R, Grant C, Longhi M, Mieli-Vergani G, Vergani D . Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev. 2014; 13(4-5):435-40. DOI: 10.1016/j.autrev.2013.11.009. View

Tesija Kuna A, derek L, Kozmar A, Drvar V . Current practice in laboratory diagnostics of autoimmune diseases in Croatia.  Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb). 2016; 26(3):376-394. PMC: 5082221. DOI: 10.11613/BM.2016.041. View

Pisetsky D . Anti-DNA antibodies--quintessential biomarkers of SLE. Nat Rev Rheumatol. 2015; 12(2):102-10. DOI: 10.1038/nrrheum.2015.151. View

10.

Abeles A, Abeles M . The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013; 126(4):342-8. DOI: 10.1016/j.amjmed.2012.09.014. View

11.

Mahler M, Fritzler M, Bluthner M . Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Res Ther. 2005; 7(1):R19-29. PMC: 1064884. DOI: 10.1186/ar1455. View

12.

Nakashima R . Clinical significance of myositis-specific autoantibodies. Immunol Med. 2019; 41(3):103-112. DOI: 10.1080/25785826.2018.1531188. View

13.

Damoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I . From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. Clin Exp Rheumatol. 2014; 32(4):539-46. View

14.

Cozzani E, Drosera M, Gasparini G, Parodi A . Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects. Autoimmune Dis. 2014; 2014:321359. PMC: 3932647. DOI: 10.1155/2014/321359. View

15.

Ochs R, Mahler M, Basu A, Rios-Colon L, Sanchez T, Andrade L . The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med. 2015; 16(3):273-93. PMC: 4684813. DOI: 10.1007/s10238-015-0367-0. View

16.

Pisetsky D . Antinuclear antibody testing - misunderstood or misbegotten?. Nat Rev Rheumatol. 2017; 13(8):495-502. DOI: 10.1038/nrrheum.2017.74. View

17.

Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F . Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002; 117(2):316-24. DOI: 10.1309/Y5VF-C3DM-L8XV-U053. View

18.

Chan E, Damoiseaux J, Carballo O, Conrad K, Cruvinel W, Francescantonio P . Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol. 2015; 6:412. PMC: 4542633. DOI: 10.3389/fimmu.2015.00412. View

19.

Soto M, Hernandez-Becerril N, Perez-Chiney A, Hernandez-Rizo A, Telich-Tarriba J, Juarez-Orozco L . Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: Analytical study in a specialized health institute, one year follow-up. Results Immunol. 2015; 5:13-22. PMC: 4625361. DOI: 10.1016/j.rinim.2013.10.003. View

20.

Tan E, FELTKAMP T, Smolen J, Butcher B, Dawkins R, Fritzler M . Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997; 40(9):1601-11. DOI: 10.1002/art.1780400909. View